ArticleJournal of gastrointestinal oncology2026

Interpreting the evidence base for fruquintinib in refractory metastatic colorectal cancer.

Jahnavi Udaikumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.